P
PLYX
Polaryx Therapeutics, Inc.
2.020
-0.050-2.42%Opening12:22 10/01 EDT
OPEN/PREV CLOSE2.030/2.020
TODAY RANGE1.975-2.080
VOL20.77K
MARKET CAP103.68M
52 WEEK RANGE1.850-48.91
AVG VOL (3M)78.28K
% TURNOVER0.04%
TURNOVER--
P/E (TTM)-18.4561
% RANGE4.55%
EPS(TTM)-0.1127
P/E(FORWARD)-10.6667
P/B9.48
BVPS0.2195
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP31.19M
SHARES OUTSTANDING49.85M
NEXT EARNINGS--
FREE FLOAT14.99M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Benzinga·6d ago
Why Webuy Global Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
TipRanks·09/01 21:27
Polaryx Therapeutics Appoints New Chief Medical Officer
NASDAQ·09/01 16:03
Polaryx Appoints Charlton As CMO; PLX-200 Set For Phase 2 In Q4 '26
TipRanks·09/01 12:40
Polaryx appoints Will Charlton as chief medical officer
TipRanks·08/25 12:40
Polaryx provides operational readiness update for SOTERIA trial
TipRanks·08/17 08:19
Polaryx initiated with a Strong Buy at Raymond James
Benzinga·08/13 16:11
This Vail Resorts Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday
Dow Jones·08/13 10:43
Polaryx Therapeutics Initiated at Strong Buy by Raymond James
Dow Jones·08/13 10:43
Polaryx Therapeutics Price Target Announced at $6.00/Share by Raymond James
Benzinga·07/31 12:05
12 Health Care Stocks Moving In Friday's Pre-Market Session
Dow Jones·07/27 12:14
Polaryx Therapeutics Initiated at Buy by LUCID CAPITAL MARKETS
Dow Jones·07/27 12:14
Polaryx Therapeutics Price Target Announced at $7.00/Share by LUCID CAPITAL MARKETS
Same Industry
Name/Symbol
Change%
Price